Literature DB >> 34711523

Spinocerebellar ataxias in Asia: Prevalence, phenotypes and management.

Teije van Prooije1, Norlinah Mohamed Ibrahim2, Shahrul Azmin2, Bart van de Warrenburg3.   

Abstract

This paper reviews and summarizes three main aspects of spinocerebellar ataxias (SCA) in the Asian population. First, epidemiological studies were comprehensively reviewed. Overall, the most common subtypes include SCA1, SCA2, SCA3, and SCA6, but there are large differences in the relative prevalence of these and other SCA subtypes between Asian countries. Some subtypes such as SCA12 and SCA31 are rather specific to certain Asian populations. Second, we summarized distinctive phenotypic manifestations of SCA patients of Asian origin, for example a frequent co-occurrence of parkinsonism in some SCA subtypes. Lastly, we have conducted an exploratory survey study to map SCA-specific expertise, resources, and management in various Asian countries. This showed large differences in accessibility, genetic testing facilities, and treatment options between lower and higher income Asian countries. Currently, many Asian SCA patients remain without a final genetic diagnosis. Lack of prevalence data on SCA, lack of patient registries, and insufficient access to genetic testing facilities hamper a wider understanding of these diseases in several (particularly lower income) Asian countries.
Copyright © 2021. Published by Elsevier Ltd.

Entities:  

Keywords:  Autosomal dominant cerebellar ataxia; Hereditary ataxias; SCAs; Spinocerebellar ataxias

Mesh:

Year:  2021        PMID: 34711523     DOI: 10.1016/j.parkreldis.2021.10.023

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  1 in total

1.  Multi-type RFC1 repeat expansions as the most common cause of hereditary sensory and autonomic neuropathy.

Authors:  Jun-Hui Yuan; Yujiro Higuchi; Masahiro Ando; Eiji Matsuura; Akihiro Hashiguchi; Akiko Yoshimura; Tomonori Nakamura; Yusuke Sakiyama; Jun Mitsui; Hiroyuki Ishiura; Shoji Tsuji; Hiroshi Takashima
Journal:  Front Neurol       Date:  2022-08-17       Impact factor: 4.086

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.